Brokerages Anticipate Surgery Partners Inc (NASDAQ:SGRY) to Post -$0.14 Earnings Per Share

Share on StockTwits

Equities analysts expect Surgery Partners Inc (NASDAQ:SGRY) to post earnings per share of ($0.14) for the current quarter, according to Zacks Investment Research. Four analysts have made estimates for Surgery Partners’ earnings. The highest EPS estimate is ($0.08) and the lowest is ($0.21). Surgery Partners reported earnings per share of ($0.18) in the same quarter last year, which would suggest a positive year-over-year growth rate of 22.2%. The company is expected to announce its next earnings results on Thursday, August 8th.

On average, analysts expect that Surgery Partners will report full-year earnings of ($0.41) per share for the current year, with EPS estimates ranging from ($0.75) to ($0.15). For the next year, analysts forecast that the company will report earnings of $0.24 per share, with EPS estimates ranging from ($0.36) to $0.62. Zacks Investment Research’s earnings per share averages are an average based on a survey of sell-side analysts that follow Surgery Partners.

Surgery Partners (NASDAQ:SGRY) last released its quarterly earnings data on Wednesday, May 8th. The company reported ($0.42) earnings per share for the quarter, missing the consensus estimate of ($0.39) by ($0.03). Surgery Partners had a negative net margin of 11.59% and a negative return on equity of 4.01%. The firm had revenue of $416.80 million during the quarter, compared to analysts’ expectations of $421.41 million. During the same period in the previous year, the business earned ($0.26) earnings per share. The business’s revenue for the quarter was up 1.3% on a year-over-year basis.

SGRY has been the subject of several research analyst reports. BidaskClub downgraded Surgery Partners from a “hold” rating to a “sell” rating in a research note on Friday, May 24th. Zacks Investment Research upgraded Surgery Partners from a “strong sell” rating to a “hold” rating in a report on Wednesday, April 24th. Finally, Stifel Nicolaus set a $12.00 target price on Surgery Partners and gave the company a “hold” rating in a report on Wednesday, May 8th. Two equities research analysts have rated the stock with a sell rating, three have assigned a hold rating and three have assigned a buy rating to the company’s stock. Surgery Partners presently has a consensus rating of “Hold” and a consensus price target of $17.60.

In other Surgery Partners news, Director Adam T. Feinstein sold 7,865 shares of the stock in a transaction on Monday, May 20th. The stock was sold at an average price of $9.95, for a total transaction of $78,256.75. Following the sale, the director now owns 8,895 shares in the company, valued at approximately $88,505.25. The sale was disclosed in a legal filing with the SEC, which is available through this link. 2.30% of the stock is currently owned by corporate insiders.

Large investors have recently made changes to their positions in the business. Quantamental Technologies LLC acquired a new stake in shares of Surgery Partners during the first quarter worth $50,000. Metropolitan Life Insurance Co. NY boosted its holdings in shares of Surgery Partners by 351.4% during the fourth quarter. Metropolitan Life Insurance Co. NY now owns 6,766 shares of the company’s stock worth $66,000 after purchasing an additional 5,267 shares during the last quarter. Menta Capital LLC acquired a new stake in shares of Surgery Partners during the fourth quarter worth $99,000. Redmile Group LLC acquired a new stake in shares of Surgery Partners during the first quarter worth $179,000. Finally, Principal Financial Group Inc. boosted its holdings in shares of Surgery Partners by 9.5% during the fourth quarter. Principal Financial Group Inc. now owns 19,325 shares of the company’s stock worth $189,000 after purchasing an additional 1,672 shares during the last quarter. Hedge funds and other institutional investors own 96.75% of the company’s stock.

NASDAQ SGRY traded down $0.16 during mid-day trading on Friday, hitting $7.90. The stock had a trading volume of 259,128 shares, compared to its average volume of 359,082. Surgery Partners has a 52-week low of $7.64 and a 52-week high of $18.70. The firm has a market cap of $390.48 million, a P/E ratio of -3.22 and a beta of 2.28. The stock has a 50 day moving average price of $8.81. The company has a current ratio of 1.49, a quick ratio of 1.37 and a debt-to-equity ratio of 2.20.

About Surgery Partners

Surgery Partners, Inc, through its subsidiaries, owns and operates a network of surgical facilities and related services in the United States. The company operates through three segments: Surgical Facility Services, Ancillary Services, and Optical Services. Its surgical facilities comprise ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including gastroenterology, general surgery, ophthalmology, orthopedics, and pain management.

Further Reading: Blue-Chip Stocks

Get a free copy of the Zacks research report on Surgery Partners (SGRY)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Surgery Partners Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Surgery Partners and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Valeritas  Lifted to Buy at Zacks Investment Research
Valeritas Lifted to Buy at Zacks Investment Research
Verastem  Raised to “Hold” at Zacks Investment Research
Verastem Raised to “Hold” at Zacks Investment Research
Acadia Healthcare Company Inc  Sees Significant Growth in Short Interest
Acadia Healthcare Company Inc Sees Significant Growth in Short Interest
Short Interest in American Software, Inc.  Grows By 11.5%
Short Interest in American Software, Inc. Grows By 11.5%
Short Interest in Activision Blizzard, Inc.  Declines By 5.5%
Short Interest in Activision Blizzard, Inc. Declines By 5.5%
Broadcom Inc  Sees Significant Increase in Short Interest
Broadcom Inc Sees Significant Increase in Short Interest


© 2006-2019 Ticker Report